![]() |
Phenomenex, a specialist in the research and manufacture of advanced technologies for the separation sciences, announces the addition of a Phenyl-Hexyl phase to its successful Kinetex core-shell HPLC/UHPLC column family. Kinetex Phenyl-Hexyl offers a unique selectivity for the separation of compounds that are difficult to resolve using traditional phenyl phases.
The new Phenyl-Hexyl columns complement the existing Kinetex phases and are especially effective for resolving aromatic hydrocarbons such as tricyclic antidepressants and explosives. Like C18, Phenyl-Hexyl is ideal for a wide range of applications, including the resolution of moderate hydrophobic compounds.
The Kinetex Phenyl-Hexyl is offered in 2.6- and 1.7-micron particle sizes.
With complementary C18 and Phenyl phases, users can screen for optimal resolution of complex sample mixtures.
Kinetex core-shell technology meets researchers' need to improve results and increase productivity without large capital expenditures. The new Phenyl-Hexyl offering brings the total number of Kinetex phases to six, and the company plans to continue expanding the choices.
Related Articles :
Keywords : Chromatography Column HPLC HPLC/UHPLC Jeremy Bierman Kinetex Phenomenex UHPLC
Phenomenex Inc.
Torrance, CA, USA
Web: http://www.phenomenex.com
Reader comments (0)